Long-Term Clinical Outcomes and Patient Satisfaction Following Ultrasound-Guided Hydrodissection for Carpal Tunnel Syndrome: Long-Term Outcomes and Satisfaction after Ultrasound-Guided Hydrodissection for CTS

TL;DR

This paper reviews long-term results and patient satisfaction with a minimally invasive treatment for carpal tunnel syndrome using ultrasound-guided fluid injection.

Contribution

The study provides a comprehensive evaluation of the long-term effectiveness and safety of ultrasound-guided hydrodissection for CTS.

Findings

USGH offers effective symptom relief for carpal tunnel syndrome with minimal complications.

Patient satisfaction remains high in the long term following the procedure.

Serious complications like nerve damage or infection are rare due to ultrasound precision.

Abstract

Carpal Tunnel Syndrome (CTS) is popular conditions in where compression of the
median nerve causes symptoms such as pain, numbness, and hand weakness in the
hand. Current treatments provide varying degree of symptom relief; however, most
are limited by short term response or long recovery. Ultrasound-Guided
Hydrodissection (USGH) has emerged as a minimally invasive alternative for
treating CTS, allowing precise injection of fluid around the median nerve under
real-time ultrasound guidance to enhance nerve mobility. Complications of USGH
are rare and mild, including short term pain, swelling, or bruising at the
injection site. Because of the precision afforded by ultrasound guidance,
serious complications, such as nerve damage or infection, are rare. This review
aimed to evaluate the long-term clinical outcomes and patient satisfaction after
USGH for CTS.